EpiCult™-C Human Medium Kit
For culture of human mammary epithelial cells
-
EpiCult™-C Human Medium Kit -
Label for EpiCult™-C Human Medium Kit -
Label for EpiCult™-C Human Medium Kit -
-
More Views
Required Products
-
Cell culture supplement -
Cell culture supplement
Overview
EpiCult™-C Medium (Human) is a serum-free culture medium optimized for the short-term culture of human mammary luminal and myoepithelial cells. This medium is also ideal for the enzymatic dissociation of human mammary tissue when supplemented with Collagenase/Hyaluronidase (Catalog #07912).
This kit contains EpiCult™-C Basal Medium (Human) and EpiCult™-C Proliferation Supplement (Human). Addition of Hydrocortisone Stock Solution (Catalog #07925) is required.
This kit contains EpiCult™-C Basal Medium (Human) and EpiCult™-C Proliferation Supplement (Human). Addition of Hydrocortisone Stock Solution (Catalog #07925) is required.
Components:
- EpiCult™-C Basal Medium (Human), 500 mL
- EpiCult™-C Proliferation Supplement (Human), 5 mL
Subtype:
Specialized Media
Cell Type:
Mammary Cells
Species:
Human
Application:
Maintenance
Brand:
EpiCult
Area of Interest:
Epithelial Cell Biology
Formulation:
Serum-Free
Related Products
-
For culture and evaluation of human mammary epithelial cells in CFU assays -
10X Collagenase/hyaluronidase in DMEM -
For culture and evaluation of mouse mammary epithelial cells -
For culture of human mammospheres and tumorspheres
Scientific Resources
Product Documentation
Document Type
Product Name
Catalog #
Lot #
Language
Educational Materials
(8)
Product Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Research Area
Workflow Stages for
Workflow Stages
STEMCELL TECHNOLOGIES INC.’S QUALITY MANAGEMENT SYSTEM IS CERTIFIED TO ISO 13485. PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.